Paul J Hastings

Director; Director, Chief Executive Officer · 3 filings · Latest: Jun 18, 2026

enGene Therapeutics Inc.

Nkarta, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
NKTX	Paul J Hastings	Director, Chief Executive Officer	Jun 18, 2026	Sale	$2.71	1,776	$4.8K	390,247	Jun 22 8:05 PM
NKTX	Paul J Hastings	Director, Chief Executive Officer	Jan 15, 2026	Sale	$2.07	26,046	$53.9K	390,023	Jan 20 10:39 PM